Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LVTX |
---|---|---|
09:32 ET | 454 | 2.32 |
09:34 ET | 100 | 2.3317 |
09:52 ET | 400 | 2.34 |
09:54 ET | 400 | 2.35 |
10:33 ET | 282 | 2.3447 |
10:35 ET | 258 | 2.38 |
11:06 ET | 600 | 2.397 |
11:13 ET | 580 | 2.34 |
11:15 ET | 100 | 2.35 |
12:03 ET | 3500 | 2.3488 |
12:20 ET | 300 | 2.3799 |
12:23 ET | 500 | 2.36 |
12:30 ET | 100 | 2.34 |
12:43 ET | 497 | 2.3689 |
12:52 ET | 100 | 2.35 |
12:54 ET | 100 | 2.345 |
12:56 ET | 1000 | 2.3463 |
12:57 ET | 988 | 2.345 |
01:01 ET | 600 | 2.345 |
01:06 ET | 100 | 2.34 |
01:17 ET | 1100 | 2.34 |
01:24 ET | 1000 | 2.34 |
01:53 ET | 125 | 2.335 |
01:57 ET | 200 | 2.34 |
02:00 ET | 1000 | 2.35 |
02:06 ET | 100 | 2.32 |
02:22 ET | 2736 | 2.31 |
02:24 ET | 1000 | 2.3 |
02:27 ET | 1100 | 2.3061 |
02:38 ET | 200 | 2.31 |
02:47 ET | 100 | 2.3 |
02:54 ET | 500 | 2.29 |
03:05 ET | 1499 | 2.3397 |
03:12 ET | 300 | 2.2948 |
03:18 ET | 200 | 2.29 |
03:21 ET | 200 | 2.315 |
03:32 ET | 171 | 2.3393 |
03:41 ET | 100 | 2.34 |
03:43 ET | 577 | 2.35 |
03:50 ET | 1100 | 2.3 |
03:52 ET | 200 | 2.33 |
03:54 ET | 1775 | 2.33 |
03:56 ET | 100 | 2.31 |
03:57 ET | 200 | 2.32 |
03:59 ET | 360 | 2.31 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
LAVA Therapeutics NV | 59.4M | -2.2x | --- |
Kezar Life Sciences Inc | 50.5M | -0.5x | --- |
BioLine RX Ltd | 58.4M | -0.9x | --- |
Kronos Bio Inc | 47.5M | -0.4x | --- |
DURECT Corp | 53.1M | -1.8x | --- |
Atara Biotherapeutics Inc | 67.5M | -0.3x | --- |
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $59.4M |
---|---|
Revenue (TTM) | $12.5M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.07 |
Book Value | $1.95 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 4.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -252.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.